When a GLP-1 (the wildly popular weight-loss medication) shipment is hijacked, inventory loss is only the first consequence. The real threat begins when that cargo is converted into counterfeit medicine.
What starts as a transit heist quickly turns into a patient safety crisis, a brand reputation disaster, and an industrial-scale counterfeiting operation. Driven by surging global demand and persistent supply shortages, organized criminal networks are heavily targeting pharmaceutical cargo.
Cargo theft to counterfeit product
The global demand of GLP-1 medications has created ideal conditions for criminal exploitation. Limited availability, premium pricing, and widespread public awareness make these products particularly attractive targets.
According to BSI Connect Screen data, up to 31% of pharmaceutical cargo theft incidents occurred while products were in transit between 2024 and 2026, with trucks accounting for nearly 70% of reported thefts. These same transportation routes carry high-demand GLP-1 products across global supply chains.
Once stolen, GLP-1 shipments generate criminal profits in two ways:
- Product diversion: Authentic medications are diverted to unregulated online or cross-border channels and sold as genuine. However, GLP-1 injectables require strict temperature-controlled storage and transportation. Once the cold chain is compromised, products can rapidly degrade even when packaging, lot numbers, and serial numbers appear authentic. These diverted products may reach patients without triggering recalls or verification alerts, creating significant safety risks.
- Counterfeit production: Stolen products, packaging materials, and delivery devices provide valuable intelligence for counterfeit manufacturers. Authentic components allow criminals to replicate product appearance, packaging design, and device functionality with increasing accuracy. As counterfeit operations become more sophisticated, distinguishing fake products from legitimate ones becomes more difficult for distributors, healthcare providers, and patients.
Mapping the illicit supply chain
Counterfeit GLP-1 networks closely mirror legitimate pharmaceutical supply chains. A shipment may be stolen in one market, counterfeited in another, and sold in a third, making these networks difficult to detect and disrupt.
South America: Theft hotspot
South America has become the fastest-rising theft hotspot, accounting for more than half of recorded pharmaceutical cargo thefts in 2026 so far, up from under a quarter the year before. High demand, limited availability, and strong resale values attract organized criminal groups. In February 2026, armed thieves stole more than 1,600 units of tirzepatide (a similar weight-loss drug) from a truck in Paraguay, prompting warnings that the shipment could quickly be redistributed across neighboring markets.
Asia-Pacific: Counterfeit production hub
Once thieves obtain products, packaging, or supply chain intelligence, counterfeit production often shifts to unauthorized manufacturing facilities. China and India remain significant sources of counterfeit GLP-1 active pharmaceutical ingredients (APIs), supported by established manufacturing and export infrastructure. Stolen packaging specifications and product designs help criminals produce increasingly convincing replicas.
North America and Europe: High-value destination markets
Counterfeit GLP-1 products ultimately flow into some of the world's highest-demand pharmaceutical markets like North America and Europe. Criminal networks use cross-border smuggling, online marketplaces, wholesale infiltration, and last-mile theft to reach patients. Seizures in the UK, Austria, and Belgium show how counterfeit products can infiltrate legitimate channels, while thefts from pharmacy deliveries in the US highlight vulnerabilities closer to the point of care.
These regions show how a localized theft event can become a mass global supply chain threat.
From stolen shipment to counterfeit product
The path from cargo theft to counterfeit medication is highly structured. Stolen products provide the materials and intelligence criminal networks need to scale counterfeit operations. Once cargo is compromised, criminals exploit it in four ways:
- Device reverse-engineering: Stolen shipments provide physical blueprints. Counterfeiters use authentic pens, needles, and patches to reverse-engineer convincing replicas.
- Chemical alteration: Counterfeiters either omit the active ingredients entirely or substitute it with cheaper, dangerous alternatives. Seized batches have revealed counterfeit semaglutide containing insulin, or banned substances such as sibutramine.
- Packaging and serialization forgery: Criminals replicate valid serialization data, including authentic lot and serial numbers, onto forged packaging. Because these units pass initial electronic database scans, standard visual inspection at the wholesale level cannot detect them.
- Substandard components: Counterfeit injectors frequently use non-sterile needles and falsified patient leaflets, introducing acute risk of infection and injury.
Securing the pharmaceutical supply chain
To actively disrupt these vulnerabilities and protect distribution networks, operational controls must be enforced:
- Audit third-party logistics: Continuously vet distributors and logistics partners to block unauthorized product entry into the supply chain.
- Protect sensitive shipment data: Enforce strict information security protocols to protect delivery routes, timetables, and transit schedules from external surveillance.
- Monitor digital marketplaces: Track unlawful e-commerce listings, social media marketplaces, and lookalike domain names.
- Share cargo intelligence: Partner with global health regulators and law enforcement to report thefts and flag duplicated serial numbers in real time.
Cargo theft resulting in inventory loss leaves supply chains dangerously susceptible to industrial-scale counterfeiting. For pharmaceutical manufacturers, the most critical intervention against illegal GLP-1 distribution starts at the point of transit.
BSI Connect Screen provides real-time visibility into global cargo theft risks, including theft hotspots, criminal methodologies, and emerging supply chain threats.
